{"entity":{"type":"insider","cik":"0001283307","url":"/insider/0001283307","json_url":"/insider/0001283307.json","name":"WORLAND STEPHEN T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2006-03-06","last":"2022-06-09","span_basis":"filed_date"},"name_variants":[{"name":"WORLAND STEPHEN T","source":"filing","n_filings":5,"first_seen":"2006-03-06","last_seen":"2022-06-09"}],"transactions":[{"id":6852394,"accession":"0001209191-22-035277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-035277","line_url":"/filing/0001209191-22-035277#line-1","is_derivative":false,"issuer_cik":"0001283307","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001283307","owner_cik":"0001283307","owner_name":"WORLAND STEPHEN T","owner_display_name":"WORLAND STEPHEN T","owner_url":"/insider/0001283307","role":"Director, Officer (President and Chief Executive)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and Chief Executive","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.37,"price_display":"1.37","price_state":"stated","total_value":27400.0,"total_display":"27,400.00","total_whole":"27,400","shares_owned_after":214978.0,"shares_owned_after_display":"214,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-07","filed_date":"2022-06-09","scope":"insider"},{"id":7024879,"accession":"0001209191-07-051841","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-07-051841","line_url":"/filing/0001209191-07-051841","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283307","owner_name":"WORLAND STEPHEN T","owner_display_name":"WORLAND STEPHEN T","owner_url":"/insider/0001283307","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13236.0,"shares_display":"13,236","price_per_share":2.3493238138410395,"price_display":"2.35","price_state":"stated","total_value":31095.65,"total_display":"31,095.65","total_whole":"31,096","shares_owned_after":207809.0,"shares_owned_after_display":"207,809","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-09-04","filed_date":"2007-09-04","scope":"insider","n_lines":2},{"id":7024875,"accession":"0001209191-07-051841","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-07-051841","line_url":"/filing/0001209191-07-051841","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283307","owner_name":"WORLAND STEPHEN T","owner_display_name":"WORLAND STEPHEN T","owner_url":"/insider/0001283307","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12200.0,"shares_display":"12,200","price_per_share":2.1077204918032786,"price_display":"2.11","price_state":"stated","total_value":25714.19,"total_display":"25,714.19","total_whole":"25,714","shares_owned_after":189487.0,"shares_owned_after_display":"189,487","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-31","filed_date":"2007-09-04","scope":"insider","n_lines":5},{"id":7024865,"accession":"0001209191-07-051841","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-051841","line_url":"/filing/0001209191-07-051841#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283307","owner_name":"WORLAND STEPHEN T","owner_display_name":"WORLAND STEPHEN T","owner_url":"/insider/0001283307","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":124564.0,"shares_display":"124,564","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":249128.0,"total_display":"249,128.00","total_whole":"249,128","shares_owned_after":183268.0,"shares_owned_after_display":"183,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-30","filed_date":"2007-09-04","scope":"insider"},{"id":3391596,"accession":"0001209191-06-018701","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-018701","line_url":"/filing/0001209191-06-018701#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283307","owner_name":"WORLAND STEPHEN T","owner_display_name":"WORLAND STEPHEN T","owner_url":"/insider/0001283307","role":"Officer (EVP, Pharmaceuticals)","role_mark":"O","role_mark_label":"Officer (EVP, Pharmaceuticals)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":64000.0,"total_display":"64,000.00","total_whole":"64,000","shares_owned_after":58704.0,"shares_owned_after_display":"58,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-16","filed_date":"2006-03-17","scope":"insider"},{"id":9261580,"accession":"0001209191-06-018698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-018698","line_url":"/filing/0001209191-06-018698#line-1","is_derivative":false,"issuer_cik":"0001283307","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001283307","owner_cik":"0001283307","owner_name":"WORLAND STEPHEN T","owner_display_name":"WORLAND STEPHEN T","owner_url":"/insider/0001283307","role":"Officer (EVP, Pharmaceuticals)","role_mark":"O","role_mark_label":"Officer (EVP, Pharmaceuticals)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":42000.0,"total_display":"42,000.00","total_whole":"42,000","shares_owned_after":62704.0,"shares_owned_after_display":"62,704","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-02","filed_date":"2006-03-17","scope":"insider"},{"id":5384000,"accession":"0001209191-06-015708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-015708","line_url":"/filing/0001209191-06-015708#line-1","is_derivative":false,"issuer_cik":"0001128495","issuer_name":"ANADYS PHARMACEUTICALS INC","issuer_ticker":"ANDS","issuer_name_source":null,"issuer_url":"/issuer/0001128495","owner_cik":"0001283307","owner_name":"WORLAND STEPHEN T","owner_display_name":"WORLAND STEPHEN T","owner_url":"/insider/0001283307","role":"Officer (EVP, Pharmaceuticals)","role_mark":"O","role_mark_label":"Officer (EVP, Pharmaceuticals)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Pharmaceuticals","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":42000.0,"total_display":"42,000.00","total_whole":"42,000","shares_owned_after":63083.0,"shares_owned_after_display":"63,083","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-03-02","filed_date":"2006-03-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001828522","name":"eFFECTOR Therapeutics, Inc.","url":"/issuer/0001828522","role":"Director, Officer (President and Chief Executive)","n_filings":1,"first_seen":"2022-06-09","last_seen":"2022-06-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001128495","name":"ANADYS PHARMACEUTICALS INC","url":"/issuer/0001128495","role":"Director, Officer (President and CEO)","n_filings":4,"first_seen":"2006-03-06","last_seen":"2007-09-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001283307","retrieved_at":"2026-08-25T20:29:05+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}